The 2015 Spring Edition of the PHSI Newsletter is now available to read here. This issue of the newsletter focuses on the newly approved biosimilar drug Zarxio® and discusses the uncertain future of biosimilars, including medical benefit coverage. If you would like to receive the newsletter electronically, click here to sign up for our e-Newsletter Mailing List!